I use a rule of thumb that doubles whatever timeline is initially expected with anything in the bio regulatory space.
Backstop low ball bid has been sitting down below for awhile so happy to fill that order if it drops today. Overall I believe the delays in trials have been a lot to do with working around lock-downs and pandemic related issues. I think the company was pretty good up until then with progress. Should get onto a more steady footing as Au opens up.
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-23
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.55M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 20.5¢ | $222.5K | 1.035M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 77810 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 23000 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |